Page last updated: 2024-10-28

miltefosine and Cancer of Pancreas

miltefosine has been researched along with Cancer of Pancreas in 2 studies

miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, J1
Seupel, R1
Bruhn, T2
Feineis, D2
Kaiser, M2
Brun, R2
Mudogo, V2
Awale, S2
Bringmann, G2
Tshitenge, DT1
Schmidt, D1
Würthner, F1

Other Studies

2 other studies available for miltefosine and Cancer of Pancreas

ArticleYear
Jozilebomines A and B, Naphthylisoquinoline Dimers from the Congolese Liana Ancistrocladus ileboensis, with Antiausterity Activities against the PANC-1 Human Pancreatic Cancer Cell Line.
    Journal of natural products, 2017, 10-27, Volume: 80, Issue:10

    Topics: Algorithms; Alkaloids; Animals; Antimalarials; Antineoplastic Agents, Phytogenic; Congo; Drug Screen

2017
Ealamines A-H, a Series of Naphthylisoquinolines with the Rare 7,8'-Coupling Site, from the Congolese Liana
    Journal of natural products, 2019, 11-22, Volume: 82, Issue:11

    Topics: Animals; Antineoplastic Agents, Phytogenic; Antiprotozoal Agents; Caryophyllales; Drug Screening Ass

2019